Vividion Therapeutics raises $82 mln

Vividion Therapeutics said April 30 that it raised $82 million in Series B financing led by Nextech Invest. New investors BVF Partners, Casdin Capital, Mubadala Ventures, Trinitas Capital, Mirae Asset Capital, Altitude Life Science Ventures, and Alexandria Venture Investments participated in the round. Existing investors ARCH Venture Partners, Versant Ventures, Cardinal Partners and Celgene Corp also took part. Vividion is a biotech that is developing discover small molecule therapeutics against biologically compelling but previously intractable targets.

North AmericaUSHealthcareBriefs